News > Sleep apnea prevalent in patients at risk of heart failure from cancer therapy

Sleep apnea prevalent in patients at risk of heart failure from cancer therapy

Sleep apnea is a breathing disorder that occurs while sleeping and is classified as either obstructive (OSA) or central (CSA). Both can be treated to reduce symptoms and enhance cardiovascular health. According to the study presented at the American College of Cardiology (ACC), among heart failure patients in the general population, OSA maintains a 48-52 per cent prevalence and is associated with heightened cardiovascular mortality and morbidity rates.